Shareholders should also be aware of several important facts in Genco's disclosures this morning:

  • Genco has once again revised its poison pill in response to shareholder feedback — demonstrating very clearly that it was, and in fact remains, overly aggressive.
  • Genco spent nearly an additional $2 million on another set of "inadequacy opinions" from Jefferies and Morgan Stanley to support its rejection of Diana's most recent premium offer. This comes on top of the more than $13 million Genco has already spent in its campaign to defeat Diana's attractive offers. This waste of shareholder funds is a direct destruction of shareholder value.

Diana urges all Genco shareholders to vote the GOLD universal proxy card "FOR" each of its six independent nominees and WITHHOLD on Genco's nominees. Diana also urges shareholders to tender their shares pursuant to Diana's tender offer at $24.80 per share in cash. The proxy vote and the tender offer are independent of each other — shareholders can and should act on both opportunities.